Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Alessio Lodola

35PUBLICATIONS
93CO-AUTHORS
Biomolecular modelling and designImmunogenetics (incl. genetic immunology)Haematological tumoursMolecular targetsProteins and peptides
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (35)

Sort by Publication Date:
|Mar 21, 2025
A Reflection on the Use of Molecular Simulation to Respond to SARS-CoV-2 Pandemic Threats.

Lorenzo Casalino, Carlos A Ramos-Guzmán, Rommie E Amaro

|Feb 20, 2025
Spirotetrahydroisoquinoline-Based Histone Deacetylase Inhibitors as New Antifibrotic Agents: Biological Evaluation in Human Fibroblasts from Bronchoalveolar Lavages of Idiopathic Pulmonary Fibrosis Patients.

Anna Fontana, Laura Bergantini, Gabriele Carullo

|Jan 17, 2025
JAK3 Inhibitors: Covalent and Noncovalent Interactions of a Cyanamide Group Investigated by Multiscale Free-Energy Simulations.

Laura Scalvini, Daniele Pala, Alberto Cuzzolin

|Jul 18, 2024
Development of Epigenetic Modifiers with Therapeutic Potential in FMS-Related Tyrosine Kinase 3/Internal Tandem Duplication (FLT3/ITD) Acute Myeloid Leukemia and Other Blood Malignancies.

Gabriele Carullo, Sara Rossi, Valentina Giudice

|Mar 19, 2024
Targeting glucosylceramide synthase induces antiproliferative and proapoptotic effects in osimertinib-resistant NSCLC cell models.

Silvia La Monica, Federica Vacondio, Kamal Eltayeb

|Jan 18, 2024
Peptidyl nitroalkene inhibitors of main protease rationalized by computational and crystallographic investigations as antivirals against SARS-CoV-2.

Francisco J Medrano, Sergio de la Hoz-Rodríguez, Sergio Martí

Pageof 6

Frequent Collaborators

20 joint publications

Marco Mor

16 joint publications

Laura Scalvini

13 joint publications

Silvia Rivara

6 joint publications

Vicent Moliner

6 joint publications

Daniele Pala

6 joint publications

Massimiliano Tognolini

6 joint publications

Francesca Galvani

5 joint publications

Gilberto Spadoni

5 joint publications

Katarzyna Świderek

5 joint publications

Carmine Giorgio

Frequent Collaborators

20 joint publications

Marco Mor

16 joint publications

Laura Scalvini

13 joint publications

Silvia Rivara

6 joint publications

Vicent Moliner

Top Related Videos

Pseudotyped Viruses As a Molecular Tool to Monitor Humoral Immune Responses Against SARS-CoV-2 Via Neutralization Assay
05:49

Pseudotyped Viruses As a Molecular Tool to Monitor Humoral Immune Responses Against SARS-CoV-2 Via Neutralization Assay

Published on : Nov 21, 2023

1.6K
Assays for Validating Histone Acetyltransferase Inhibitors
09:11

Assays for Validating Histone Acetyltransferase Inhibitors

Published on : Aug 06, 2020

6.5K
Antagonistic Effect of Jiawei Shengjiang San on a Rat Model of Diabetic Nephropathy: Related to EGFR/MAPK3/1 Signaling Pathway
08:15

Antagonistic Effect of Jiawei Shengjiang San on a Rat Model of Diabetic Nephropathy: Related to EGFR/MAPK3/1 Signaling Pathway

Published on : May 10, 2024

493
See more related videos

Top Related Videos

Pseudotyped Viruses As a Molecular Tool to Monitor Humoral Immune Responses Against SARS-CoV-2 Via Neutralization Assay
05:49

Pseudotyped Viruses As a Molecular Tool to Monitor Humoral Immune Responses Against SARS-CoV-2 Via Neutralization Assay

Published on : Nov 21, 2023

1.6K
Assays for Validating Histone Acetyltransferase Inhibitors
09:11

Assays for Validating Histone Acetyltransferase Inhibitors

Published on : Aug 06, 2020

6.5K
Antagonistic Effect of Jiawei Shengjiang San on a Rat Model of Diabetic Nephropathy: Related to EGFR/MAPK3/1 Signaling Pathway
08:15

Antagonistic Effect of Jiawei Shengjiang San on a Rat Model of Diabetic Nephropathy: Related to EGFR/MAPK3/1 Signaling Pathway

Published on : May 10, 2024

493
See more related videos